Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
9 p, 203.7 KB Outcomes of men with HIV and germ cell cancer : Results from an international collaborative study / Hentrich, Marcus Ulrich (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Bower, Mark (National Centre for HIV Malignancy. Chelsea and Westminster Hospital) ; Daugaard, Gedske (Department of Oncology. University Hospital Copenhagen. Rigshospitalet) ; Dieing, Annette (Department of Hematology and Oncology. Vivantes Klinikum am Urban) ; Bickel, Markus (Infektiologikum) ; Berretta, Massimiliano (Department of Clinical and Experimental Medicine. University of Messina) ; Lesmeister, Florian (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Jurinovic, Vindi (Institute of Biometrics and Epidemiology. Ludwig Maximilian University of Munich) ; Stoehr, Albrecht (Institute for Interdisciplinary Medicine) ; Heinzelbecker, Julia (Department of Urology and Pediatric Urology. Saarland University Medical Center and Saarland University) ; Krznaric, Ivanka (Practice of Infectious Diseases) ; Dieckmann, Klaus-Peter (Department of Urology. Asklepios Klinik Altona) ; Necchi, Andrea (IRCCS San Raffaele Hospital and Scientific Institute. Vita-Salute San Raffaele University) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Rockstroh, Jürgen Kurt (Department of Medicine I. University Hospital Bonn) ; Brito, Margarida (Instituto Português de Oncologia Francisco Gentil) ; Pfister, David (Department of Urology. University Hospital Cologne) ; Hoffmann, Christian (University Hospital of Schleswig Holstein)
Background: Previous studies have shown that men with HIV and germ cell cancer (HIV-GCC) have inferior overall survival (OS) in comparison with their HIV-negative counterparts. However, little information is available on treatments and outcomes of HIV-GCC in the era of combination antiretroviral therapy (cART). [...]
2022 - 10.1002/cncr.33928
Cancer, Vol. 128 Núm. 2 (January 2022) , p. 260-268  
2.
11 p, 2.5 MB Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy : Systematic Review and Meta-Analysis / Krajewski, Wojciech (Wrocław Medical University (Wroclaw, Polònia)) ; Nowak, Łukasz (Wrocław Medical University (Wroclaw, Polònia)) ; Moschini, Marco (Luzerner Kantonsspital, Lucerne, Switzerland) ; Poletajew, Sławomir (Centre of Postgraduate Medical Education, Warsaw, Poland) ; Chorbińska, Joanna (Wrocław Medical University (Wroclaw, Polònia)) ; Necchi, Andrea (Fondazione IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Montorsi, Francesco (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ; Sanchez-Salas, Rafael (Université Paris-Descartes, Paris, France) ; Shariat, Shahrokh F. (Charles University, Prague, Czech Republic) ; Palou, Juan ; Babjuk, Marek (Institut d'Investigació Biomèdica Sant Pau) ; Teoh, Jeremy Y. C. (The Chinese University of Hong Kong, Hong Kong) ; Soria, Francesco (San Giovanni Battista Hospital) ; Pradere, Benjamin (University Hospital of Tours, Tours) ; Ornaghi, Paola Irene (Luzerner Kantonsspital, Lucerne, Switzerland) ; Pawlak, Aleksandra (Wroclaw University of Environmental and Life Sciences, Wrocław, Poland) ; Dembowski, Janusz (Wrocław Medical University (Wroclaw, Polònia)) ; Zdrojowy, Romuald (Wrocław Medical University (Wroclaw, Polònia)) ; Universitat Autònoma de Barcelona
Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) with pelvic lymph-node dissection is the standard treatment for cT2-4a cN0 cM0 muscle-invasive bladder cancer (MIBC). [...]
2021 - 10.3390/jcm10040651
Journal of clinical medicine, Vol. 10 (february 2021)  

See also: similar author names
1 Necchi, A.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.